AGI Dermatics President to Speak at Asian Society of Cosmetic Scientists Conference
Yarosh Presents Data on Use of DNA Repair Enzymes in Reversing Sun Damage
Freeport, NY (March 7, 2007) -- Daniel B.Yarosh, PhD, President, AGI Dermatics delivered a keynote address entitled "It's Not Too Late: DNA Repair and Photoaging," today at the Asian Society of Cosmetic Scientists (ASCS) 8th annual conference in Singapore. The ASCS is a forum for cooperation among the Societies of Cosmetic Scientists/Chemists in 10 member countries dedicated to fostering discussion and sharing of information within the profession.
"Scientists know that DNA damage is a significant cause of skin cancer and a central mechanism of photoaging," said Dr. Yarosh. "Clinical studies indicate that an effective DNA repair system can reverse past sun damage and reduce or delay the effects of photoaging on adult skin and may even have a role in preventing skin cancer." Dr. Yarosh shared clinical findings for treatment of patients with xeroderma pigmentosum (XP) who have a genetic defect that leads to drastically increased skin cancer incidence. Experimental treatment with proprietary DNA repair enzymes led to a reduction in sunburn erythema and skin cancer incidence. In separate studies, DNA repair enzymes were shown to reduce UV-induced wrinkles.
"There is a popular misconception that most sun exposure occurs during childhood," said Dr. Yarosh. "Actually, we receive the same amount of UV exposure as adults as we do as children. Thus, the promise of DNA repair represents tremendous hope for people of all ages in reversing the damage of photoaged skin."
Dr. Yarosh, widely recognized as a pioneer in the science of DNA repair, is the author of more than 100 scientific papers and two dozen patents. He is an active participant in international photobiology societies and the New York biotechnology community.
AGI Dermatics founded by Dr. Yarosh in 1985, has emerged as a world leader in DNA repair technology for skin and is best known for developing Dimericinẻ, a drug that is under clinical testing for treating patients with skin cancers and pre-cancers. AGI Dermatics is also the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair.
# # #
AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals.
